韩国BRAFV600E突变高流行区甲状腺乳头状癌的分子特征分析
该研究分析了769例术前细针穿刺标本及切除的甲状腺乳头状癌(PTC)中BRAF、RAS基因突变及RET/PTC1、NTRK1、ALK基因重排,发现89.3%存在分子改变,BRAFV600E最常见(80.8%),NIFTP在PTC中占2.7%,其遗传改变在不同组织学亚型间存在显著差异。
要点
- 769例PTC中89.3%存在分子改变,BRAFV600E突变占80.8%,RAS突变占5.6%。
- RET/PTC1、NTRK1、ALK重排分别占2.1%、0.4%、0%。
- NIFTP在PTC中占2.7%,其中28.6%有BRAF突变,57.1%有RAS突变。
核心结论
- PTC的遗传改变在不同组织学亚型间存在差异,且在不同种族间似乎不同。
研究设计与样本
- 研究分析了769例术前细针穿刺标本及切除的PTC中BRAF和RAS基因突变及RET/PTC1、NTRK1、ALK基因重排。
主要发现
- 769例PTC中687例(89.3%)发现分子改变。
- BRAFV600E突变最常见(80.8%),其次为RAS突变(5.6%)、RET/PTC1重排(2.1%)、NTRK1重排(0.4%)、ALK重排(0%)。
- NIFTP在PTC中占2.7%,NIFTP中BRAF和RAS突变分别占28.6%和57.1%。
- NIFTP与包裹性滤泡亚型PTC伴包膜侵犯组在临床病理因素和突变谱上无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The BRAFV600E mutation in papillary thyroid carcinoma (PTC) is particularly prevalent in Korea, and a considerable number of wild-type BRAF PTCs harbor RAS mutations. In addition, subsets of other genetic alterations clearly exist, but their prevalence in the Korean population has not been well studied. Recent increased insight into noninvasive encapsulated follicular variant PTC has prompted endocrine pathologists to reclassify this entity as "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" (NIFTP). This study analyzed the genetic alterations among the histologic variants of PTC, including NIFTP. METHODS: Mutations of the BRAF and RAS genes and rearrangement of the RET/PTC1, NTRK1, and ALK genes using 769 preoperative fine-needle aspiration specimens and resected PTCs were analyzed. RESULTS: Molecular alterations were found in 687 (89.3%) of 769 PTCs. BRAFV600E mutation (80.8%) was the most frequent alteration, followed by RAS mutation and RET/PTC1, NTRK1, and ALK rearrangements (5.6%, 2.1%, 0.4%, and 0%, respectively). The low prevalence of NTRK1 fusions and the absence of an ALK fusion detected in Korea may also be attributed to the higher prevalence of the BRAFV600E mutation. There were significant differences in the frequency of the genetic alterations among the histologic variants of PTC. The prevalence of NIFTP in PTC was 2.7%, and among the NIFTPs, 28.6% and 57.1% harbored BRAF and RAS mutations, respectively. Clinicopathologic factors and mutational profiles between NIFTP and encapsulated follicular variant PTC with capsular invasion group were not significantly different. CONCLUSIONS: Genetic alterations in PTC vary among its different histologic variants and seem to be different in each ethnic group.
引用
- Lee SE, Hwang TS, Choi YL, et al. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation. Thyroid. 2017. PMID: 28293988. doi:10.1089/thy.2016.0547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。